Articles NICE and Highly Specialised Technologies: three years on Leela Barham examines the process for the appraisal of Highly Specialised Technologies.
News NHS under fire for delaying access to rare disease cholester... Pharma concerned by fairness and transparency of NHS England's Prioritisation Framework
Articles Accelerating health technologies with NICE Office for Market... England's health watchdog launched its service to speed the delivery of new technologies in October 2015.
Digital An AI supercomputer and discovering next-gen brain disorder ... Tarek Samad, Lundbeck’s senior vice president and head of research, discusses AI – specifically, Lundbeck’s agreement with the DCAI to operate Gefion.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
